Deregulated tyrosine-phenylalanine metabolism in pulmonary tuberculosis patientS

Journal of Proteome Research

Volumn 14, Issue 4, 2015, Pages 1947-1956

  Das, Mrinal Kumar ^a   Bishwal, Subasa Chandra ^a   Das, Aleena ^a   Dabral, Deepti ^a,d   Badireddy, Vinod Kumar ^a   Pandit, Bhaswati ^b   Varghese, George M ^c   Nanda, Ranjan Kumar ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b National Institute of Biomedical Genomics   (India)

^c CHRISTIAN MEDICAL COLLEGE   (India)

^d TATA INSTITUTE OF FUNDAMENTAL RESEARCH   (India)

Author keywords

GC MS; metabolomics; silyalation; tuberculosis; tyrosine phenylalanine metabolism; urine analysis

Indexed keywords

4 HYDROXYBENZOIC ACID; ETHAMBUTOL; GENTISIC ACID; HYDROQUINONE; ISONIAZID; NORADRENALIN; PHENYLALANINE; PYRAZINAMIDE; RIFAMPICIN; SALICYLURIC ACID; TYROSINE; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AMINO ACID METABOLISM; ARTICLE; CHEMOMETRIC ANALYSIS; CHEMOMETRICS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; LONGITUDINAL STUDY; LUNG TUBERCULOSIS; MALE; MASS FRAGMENTOGRAPHY; PILOT STUDY; PRIORITY JOURNAL; PURINE METABOLISM; SHORT COURSE THERAPY; SILYLATION; TYROSINE PHENYLALANINE METABOLISM; URINALYSIS; DISCRIMINANT ANALYSIS; METABOLISM; METABOLOME; PATHOPHYSIOLOGY; PHYSIOLOGY; RECEIVER OPERATING CHARACTERISTIC; URINE;

BIOMARKERS; DISCRIMINANT ANALYSIS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LONGITUDINAL STUDIES; METABOLIC NETWORKS AND PATHWAYS; METABOLOME; PHENYLALANINE; PILOT PROJECTS; ROC CURVE; TUBERCULOSIS, PULMONARY; TYROSINE;

EID: 84926443456     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/acs.jproteome.5b00016     Document Type: Article

References (44)

1. WHO. Global Tuberculosis Report 2014; WHO: Geneva, 2014.
2. Kaufmann, S. H.; Lange, C.; Rao, M.; Balaji, K. N.; Lotze, M.; Schito, M.; Zumla, A. I.; Maeurer, M. Progress in tuberculosis vaccine development and host-directed therapies - a state of the art review Lancet Respir. Med. 2014, 2 (4) 301-320
3. Smith, R. Eradication of tuberculosis by 2050 impossible without new vaccine BMJ 2009, 338, b1291
4. Herrera, V.; Perry, S.; Parsonnet, J.; Banaei, N. Clinical application and limitations of interferon-gamma release assays for the diagnosis of latent tuberculosis infection Clin. Infect. Dis. 2011, 52 (8) 1031-1037
5. M?ller, M.; Hoal, E. G. Current findings, challenges and novel approaches in human genetic susceptibility to tuberculosis Tuberculosis 2010, 90 (2) 71-83
6. Zumla, A. I.; Gillespie, S. H.; Hoelscher, M.; Philips, P. P.; Cole, S. T.; Abubakar, I.; McHugh, T. D.; Schito, M.; Maeurer, M.; Nunn, A. J. New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects Lancet Infect. Dis. 2014, 14 (4) 327-340
7. Blankley, S.; Berry, M. P.; Graham, C. M.; Bloom, C. I.; Lipman, M.; OGarra, A. The application of transcriptional blood signatures to enhance our understanding of the host response to infection: the example of tuberculosis Philos. Trans. R. Soc., B 2014, 369 (1645) 20130427
8. Yanes, O.; Clark, J.; Wong, D. M.; Patti, G. J.; Sanchez-Ruiz, A.; Benton, H. P.; Trauger, S. A.; Desponts, C.; Ding, S.; Siuzdak, G. Metabolic oxidation regulates embryonic stem cell differentiation Nat. Chem. Biol. 2010, 6 (6) 411-417
9. Che, N.; Cheng, J.; Li, H.; Zhang, Z.; Zhang, X.; Ding, Z.; Dong, F.; Li, C. Decreased serum 5-oxoproline in TB patients is associated with pathological damage of the lung Clin. Chim. Acta 2013, 423, 5-9
10. du Preez, I.; Loots, D. T. New sputum metabolite markers implicating adaptations of the host to Mycobacterium tuberculosis, and vice versa Tuberculosis 2013, 93 (3) 330-337
11. Mahapatra, S.; Hess, A. M.; Johnson, J. L.; Eisenach, K. D.; DeGroote, M. A.; Gitta, P.; Joloba, M. L.; Kaplan, G.; Walzl, G.; Boom, W. H.; Belisle, J. T. A metabolic biosignature of early response to anti-tuberculosis treatment BMC Infect. Dis. 2014, 14, 53
12. Shin, J. H.; Yang, J. Y.; Jeon, B. Y.; Yoon, Y. J.; Cho, S. N.; Kang, Y. H.; Ryu do, H.; Hwang, G. S. (1)H NMR-based metabolomic profiling in mice infected with Mycobacterium tuberculosis J. Proteome Res. 2011, 10 (5) 2238-2247
13. Somashekar, B. S.; Amin, A. G.; Rithner, C. D.; Troudt, J.; Basaraba, R.; Izzo, A.; Crick, D. C.; Chatterjee, D. Metabolic profiling of lung granuloma in Mycobacterium tuberculosis infected guinea pigs: ex vivo 1H magic angle spinning NMR studies J. Proteome Res. 2011, 10 (9) 4186-4195
14. Weiner, J., 3rd; Parida, S. K.; Maertzdorf, J.; Black, G. F.; Repsilber, D.; Telaar, A.; Mohney, R. P.; Arndt-Sullivan, C.; Ganoza, C. A.; Fae, K. C.; Walzl, G.; Kaufmann, S. H. Biomarkers of inflammation, immunosuppression and stress with active disease are revealed by metabolomic profiling of tuberculosis patients PLoS One 2012, 7 (7) e40221
15. Zhou, A.; Ni, J.; Xu, Z.; Wang, Y.; Lu, S.; Sha, W.; Karakousis, P. C.; Yao, Y. F. Application of (1)h NMR spectroscopy-based metabolomics to sera of tuberculosis patients J. Proteome Res. 2013, 12 (10) 4642-4649
16. Want, E. J.; Wilson, I. D.; Gika, H.; Theodoridis, G.; Plumb, R. S.; Shockcor, J.; Holmes, E.; Nicholson, J. K. Global metabolic profiling procedures for urine using UPLC-MS Nat. Protoc. 2010, 5 (6) 1005-1018
17. Berry, M. P.; Graham, C. M.; McNab, F. W.; Xu, Z.; Bloch, S. A.; Oni, T.; Wilkinson, K. A.; Banchereau, R.; Skinner, J.; Wilkinson, R. J.; Quinn, C.; Blankenship, D.; Dhawan, R.; Cush, J. J.; Mejias, A.; Ramilo, O.; Kon, O. M.; Pascual, V.; Banchereau, J.; Chaussabel, D.; OGarra, A. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis Nature 2010, 466 (7309) 973-977
18. De Groote, M. A.; Nahid, P.; Jarlsberg, L.; Johnson, J. L.; Weiner, M.; Muzanyi, G.; Janjic, N.; Sterling, D. G.; Ochsner, U. A. Elucidating novel serum biomarkers associated with pulmonary tuberculosis treatment PLoS One 2013, 8 (4) e61002
19. Bouatra, S.; Aziat, F.; Mandal, R.; Guo, A. C.; Wilson, M. R.; Knox, C.; Bjorndahl, T. C.; Krishnamurthy, R.; Saleem, F.; Liu, P.; Dame, Z. T.; Poelzer, J.; Huynh, J.; Yallou, F. S.; Psychogios, N.; Dong, E.; Bogumil, R.; Roehring, C.; Wishart, D. S. The human urine metabolome PLoS One 2013, 8 (9) e73076
20. Banday, K. M.; Pasikanti, K. K.; Chan, E. C.; Singla, R.; Rao, K. V.; Chauhan, V. S.; Nanda, R. K. Use of urine volatile organic compounds to discriminate tuberculosis patients from healthy subjects Anal. Chem. 2011, 83 (14) 5526-5534
21. Sangster, T.; Major, H.; Plumb, R.; Wilson, A. J.; Wilson, I. D. A pragmatic and readily implemented quality control strategy for HPLC-MS and GC-MS-based metabonomic analysis Analyst 2006, 131 (10) 1075-1078
22. Dunn, W. B.; Broadhurst, D.; Begley, P.; Zelena, E.; Francis-McIntyre, S.; Anderson, N.; Brown, M.; Knowles, J. D.; Halsall, A.; Haselden, J. N.; Nicholls, A. W.; Wilson, I. D.; Kell, D. B.; Goodacre, R. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry Nat. Protoc. 2011, 6 (7) 1060-1083
23. Chan, E. C.; Pasikanti, K. K.; Nicholson, J. K. Global urinary metabolic profiling procedures using gas chromatography-mass spectrometry Nat. Protoc. 2011, 6 (10) 1483-1499
24. Xia, J.; Wishart, D. S. Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst Nat. Protoc. 2011, 6 (6) 743-760
25. Xia, J.; Broadhurst, D. I.; Wilson, M.; Wishart, D. S. Translational biomarker discovery in clinical metabolomics: an introductory tutorial Metabolomics 2013, 9 (2) 280-299
26. Wallace, M.; Hashim, Y. Z.; Wingfield, M.; Culliton, M.; McAuliffe, F.; Gibney, M. J.; Brennan, L. Effects of menstrual cycle phase on metabolomic profiles in premenopausal women Hum. Reprod. 2010, 25 (4) 949-956
27. Xu, X.; Duncan, A. M.; Merz-Demlow, B. E.; Phipps, W. R.; Kurzer, M. S. Menstrual cycle effects on urinary estrogen metabolites J. Clin. Endocrinol. Metab. 1999, 84 (11) 3914-3918
28. Lis, A. W.; McLaughlin, I.; Mpclaughlin, R. K.; Lis, E. W.; Stubbs, E. G. Profiles of ultraviolet-absorbing components of urine from autistic children, as obtained by high-resolution ion-exchange chromatography Clin. Chem. 1976, 22 (9) 1528-1532
29. Wikoff, W. R.; Anfora, A. T.; Liu, J.; Schultz, P. G.; Lesley, S. A.; Peters, E. C.; Siuzdak, G. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites Proc. Natl. Acad. Sci. U. S. A. 2009, 106 (10) 3698-3703
30. Nicholson, J. K.; Holmes, E.; Kinross, J.; Burcelin, R.; Gibson, G.; Jia, W.; Pettersson, S. Host-gut microbiota metabolic interactions Science 2012, 336 (6086) 1262-1267
31. Clayton, T. A. Metabolic differences underlying two distinct rat urinary phenotypes, a suggested role for gut microbial metabolism of phenylalanine and a possible connection to autism FEBS Lett. 2012, 586 (7) 956-961
32. Winglee, K.; Eloe-Fadrosh, E.; Gupta, S.; Guo, H.; Fraser, C.; Bishai, W. Aerosol Mycobacterium tuberculosis infection causes rapid loss of diversity in gut microbiota PLoS One 2014, 9 (5) e97048
33. Vaccarezza, J. R.; Ruiz, D. C. The excretion of a urinary metabolite of epinephrine and norepinephrine in tuberculosis Am. Rev. Respir. Dis. 1969, 100 (3) 398-400
34. Hafeiz, A. A.; Issa, H. A.; el-Kammah, B.; Abdel-Hafez, M. A.; Abdou, M. A.; Abdel-Khalek, M.; Ramadan, S. M. Plasma catecholamines in pulmonary tuberculosis Kekkaku 1992, 67 (10) 647-652
35. Flierl, M. A.; Rittirsch, D.; Nadeau, B. A.; Chen, A. J.; Sarma, J. V.; Zetoune, F. S.; McGuire, S. R.; List, R. P.; Day, D. E.; Hoesel, L. M.; Gao, H.; Van Rooijen, N.; Huber-Lang, M. S.; Neubig, R. R.; Ward, P. A. Phagocyte-derived catecholamines enhance acute inflammatory injury Nature 2007, 449 (7163) 721-725
36. Bergquist, J.; Tarkowski, A.; Ekman, R.; Ewing, A. Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of lymphocyte function via an autocrine loop Proc. Natl. Acad. Sci. U. S. A. 1994, 91 (26) 12912-12916
37. Alaniz, R. C.; Thomas, S. A.; Perez-Melgosa, M.; Mueller, K.; Farr, A. G.; Palmiter, R. D.; Wilson, C. B. Dopamine beta-hydroxylase deficiency impairs cellular immunity Proc. Natl. Acad. Sci. U. S. A. 1999, 96 (5) 2274-2278
38. Rohini, K.; Bhat, S.; Srikumar, P. S.; Mahesh Kumar, A. Assessment of serum calcium and phosphorus in pulmonary tuberculosis patients before, during and after chemotherapy Indian J. Clin. Biochem. 2014, 29 (3) 377-381
39. Fukumoto, S. Phosphate metabolism and vitamin D Bonekey Rep. 2014, 3, 497
40. Gibney, K. B.; MacGregor, L.; Leder, K.; Torresi, J.; Marshall, C.; Ebeling, P. R.; Biggs, B. A. Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa Clin. Infect. Dis. 2008, 46 (3) 443-446
41. Brown, G. K.; Cromby, C. H.; Manning, N. J.; Pollitt, R. J. Urinary organic acids in succinic semialdehyde dehydrogenase deficiency: evidence of alpha-oxidation of 4-hydroxybutyric acid, interaction of succinic semialdehyde with pyruvate dehydrogenase and possible secondary inhibition of mitochondrial beta-oxidation J. Inherited Metab. Dis. 1987, 10 (4) 367-375
42. Chan, C. H.; Lai, C. K.; Leung, J. C.; Ho, A. S.; Lai, K. N. Elevated interleukin-2 receptor level in patients with active pulmonary tuberculosis and the changes following anti-tuberculosis chemotherapy Eur. Respir. J. 1995, 8 (1) 70-73
43. da Silva, M. V.; Figueiredo, A. A.; Machado, J. R.; Castellano, L. C.; Alexandre, P. B.; Oliveira, R. F.; Faria, G. E.; Pereira, S. A.; Rodrigues, D. B.; Rodrigues, V., Jr. T Cell Activation and Proinflammatory Cytokine Production in Clinically Cured Tuberculosis Are Time-Dependent and Accompanied by Upregulation of IL-10 PLoS One 2013, 8 (6) e65492
44. Demir, T.; Yalcinoz, C.; Keskinel, I.; Demiroz, F.; Yildirim, N. sICAM-1 as a serum marker in the diagnosis and follow-up of treatment of pulmonary tuberculosis Int. J. Tuberc. Lung Dis. 2002, 6 (2) 155-159